It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Wegovy is FDA-approved for weight loss; the doses go up to 2.4mg. Ozempic is only approved for treating type-2 diabetes, and ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

Third quarter sales of Novo’s in-demand obesity drug totaled $2.5 billion, roughly 81% higher than the same period in 2023 ...

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

The Food and Drug Administration has updated labels for popular weight loss drugs like Ozempic and Wegovy. NFL News: ...

In a 72-week study, 37% of participants receiving Wegovy saw improvement in liver fibrosis, compared to 22.5% in the placebo group. Novo Nordisk said it plans to seek an expanded Wegovy label in 2025.